Clinical Trial

The Acute Interference of Biotin in Blood Analysis

Study acronym: ABBA
Recruiting
View on ClinicalTrials.gov →
Summary
Biotin, also known as vitamin B7, is a water-soluble vitamin. It is essential for several metabolic processes in the body, including glucose, lipid, and protein metabolism, as it acts as a coenzyme in several carboxylation reactions. Biotin, available as an over the counter supplement, is widely used to improve nail and hair growth. The use of biotin supplements can interfere with various laboratory tests, due to the use of the streptavidin-biotin interaction in several immunoassays. The investigators therefore wish to assess the acute impact of biotin supplementation on various laboratory assays, with focus on the immediate post-ingestion effects and the time frame in which biotin interference is most pronounced.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-11.
Status change: Not Yet Recruiting → Recruiting 2026-04-29
Trial Details
NCT Number NCT07302880
Lead Sponsor University of Copenhagen
Collaborators: Bispebjerg Hospital
Conditions Blood Sample, Interference With Routine Analyical Tests, Biotin Ingestion
Enrollment 24 participants
Start Date 2026-03-17
Primary Completion 2030-03-01 (estimated)
Study Completion 2030-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-06